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ABSTRACT
BACKGROUND: Several studies have supported the idea that 
smoking induces changes with direct impact on endothelial function 
and arterial stiffness. The main purpose of this study was to assess 
the acute effects of smoking on vascular function in healthy young 
adults. 
METHODS: We designed a quasi-experimental study, including 
ninety participants aged between 18 and 25 years. Participants were 
divided into three groups: Active exposure group (AG) - 30 usual 
smokers; passive exposure group (PG) and non-exposure control 
group (CG), each including 30 non-smokers matched for age, gender 
and overall lifestyle. Heart rate (HR), brachial blood pressure (bBP), 
flow-mediated dilation (FMD), aortic pulse wave velocity (PWV) and 
carotid pulse wave analysis (PWA) were evaluated in two moments: 
baseline and 30 minutes after smoking exposition (AG and PG) or 30 
minutes after the first evaluation (CG). 
RESULTS: Significant changes from baseline were observed only in 
the AG, with an increase in PWV, from 5.6 ± 0.7 m/s to 6.1 ± 0.2 m/
s post-smoking (p = 0.040), and a decrease in FMD of about -5.7 ± 
2.3% after smoking one cigarette (p < 0.001). A significant increase 
in brachial and central BP was also observed in the AG. A trend for 
increase in brachial and central BP, and decrease in the FMD was 
observed in the PG and no significant changes were depicted in the CG. 
CONCLUSION: Just one cigarette produces significant detrimental 
acute effects on the vascular endothelium and hemodynamic profile 
of healthy young short-term smokers. Changes are also observed, 
although to a lesser extent, in passive smokers.
Key words: Smoking; Endothelial Dysfunction; Arterial Stiffness; 
Risk Factors
Key points: Smoking impairs vascular function in young healthy 
short-term smokers; Smoking one cigarette acutely and significantly 
depresses endothelial function; Smoking one cigarette increases 
immediately arterial stiffness; Endothelial-dependent vasodilation is 
acutely depressed in young smokers.
© 2019 The Author(s). Published by ACT Publishing Group Ltd. All 
rights reserved.
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INTRODUCTION
According to the World Health Organization (WHO), smoking 
accounts for over 8% of the deaths worldwide, being the leading 
cause of avoidable and preventable disease in the western world 
and a major risk factor for the development and progression of 
cardiovascular diseases[1]. Passive smoking has also been linked to an 
increased risk of dying from atherosclerotic heart disease[2]. 
    Smoking has been linked to arterial stiffness and to accelerated 
sclerotic processes affecting both the larger and the smaller arteries[3-9]. 
Induced endothelial dysfunction, an important precursor event in 
the atherosclerotic continuum, has been proposed as the prevailing 
mechanism underlying the vascular injury associated with long-
term smoking[5]. However, the majority of the studies supporting this 
pathophysiological link were performed in middle aged adults, with 
long-term exposition to smoking[3,4,6,8]. Fewer studies have addressed 
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champion® N; Riester, India). With the patient in supine position, we 
obtained both values through the right brachial artery, with the cuff 
at heart level and adjusted to the arm circumference about 2 to 3 cm 
above the antecubital fossa. Three measurements were performed at 1 
minute intervals, and the arithmetic mean of the three measurements 
was considered for analysis. We measured brachial systolic and 
diastolic BP (bSBP and bDBP, respectively), and the HR. Brachial 
pulse pressure (bPP) was calculated as bSBP - bDBP, and brachial 
mean arterial pressure (bMAP) was estimated as bDBP + (bPP/3). 
As blood pressure consists of both a steady component (bMAP) and 
a pulsatile component (bPP), these BP components add relevant 
information to the hemodynamic characterization of the participants, 
with bMAP being mainly determined for the ventricle ejection and 
peripheral vascular resistance and bPP for the viscoelastic properties 
of the large arteries and the wave reflection[13,14].
    Aortic pulse wave velocity and carotid pulse wave analysis 
Carotid-femoral pulse wave analysis (PWV), a measure of aortic 
stiffness, and carotid pulse wave analysis (PWA), were assessed 
simultaneously with the Complior® Analyse device (Alam Medical, 
Saint-Quentin-Fallavier, France) according to a previously described 
technique[13,15,16]. The measurements were made with the subjects in 
supine position with the neck in a slight hyperextension, and slightly 
rotated to the left, after a resting period of 10 minutes. Brachial 
blood pressure (bBP) was measured and entered on the Complior® 
Analyse software, and then signal acquisition was launched. 
When the operator observed pulse waveforms of adequate quality, 
simultaneous carotid and femoral pressure curves were recorded 
for 15 seconds. The distance travelled by the pulse waveforms was 
measured between the two recording sites directly on the body 
surface, and was automatically corrected according to the equation 
“0.8 x direct distance”, subtracting the manubrium-to-carotid distance 
as previously recommended[13]. The aortic transit time was calculated 
according to the intersecting tangent algorithm, as previously 
recommended[13]. PWV was then calculated using measurements 
of transit time and corrected distance travelled by the pulse wave, 
between the two recording sites: . 
    The averaged carotid waveform for pulse wave analysis was 
extracted from the 15 seconds recording window of carotid pulse 
waves acquired during the PWV procedure, and were calibrated 
with brachial diastolic pressure (bDBP) and mean arterial pressure 
(bMAP). The pressure curve was analysed, and its morphological and 
temporal components were extracted for analysis. Central systolic 
blood pressure (cSBP), central pulse pressure (cPP) and augmentation 
index (Aix) were assessed by analysing the morphology and timeline 
of the curves.
    All measurements were performed by a highly experienced 
operator, with high reproducibility scores, as previously published[15], 
and a noteworthy concordance between invasive arterial parameters 
and the Complior-based pulse wave analysis method, which also 
been previously documented[16].
Flow-Mediated Dilation
The assessment of FMD was performed by ultrasonography using 
a Vivid i® ultrasound system, (GE Healthcare, USA) equipped 
with a 10L linear vascular transducer (frequency range: 7-12MHz), 
according to a previously described method[17,18].
    With the participant in supine position, after a resting period 
of 10 minutes in a quiet environmental, the right brachial artery 
was identified with ultrasound imaging and color Doppler in its 
longitudinal section, on the medial aspect of the arm, about 2-3 cm 
above the antecubital fossa. 
the acute effects of smoking, particularly in young short-term 
smokers, thus, the real effects of acute exposure to tobacco may be 
underestimated due to possible long-term adaptations to continuous 
vascular aggression. Also, such acute effects over passive smokers are 
not well described, although evidence exists demonstrating adverse 
consequences of such indirect exposition[9]. In fact, cigarettes burn at 
a higher temperature during inhalation, which breaks down or filters 
some toxic components of tobacco. Considering that the majority of 
the environmental tobacco smoke consists of sidestream smoke (from 
the burning ends of cigarettes), with only 15% resulting from exhaled 
mainstream smoke, the sidestream smoke has higher concentrations 
of many toxic constituents to which passive smokers are exposed[3,4,5].
    Even so, the endothelium-dependent vasodilation was shown to be 
impaired in apparently healthy young smokers in one study[7]. Also, 
according to Celermajer et al[10], endothelial dysfunction may occur 
in the systemic arteries of healthy teenagers and young adults as a 
result of passive smoking, which can be related with reduced nitric 
oxide (NO) bioavailability. A few studies addressing arterial stiffness 
have also shown an increase in pulse wave velocity (PWV) after 
acute smoking[2,4,8], and changes in aortic pressure waveform after 
acute exposure to second-hand smoke[9].
    Most previous research has been focused on the long-term 
effects of smoking. Notwithstanding, the understanding of the 
impact of a single cigarette would add relevant information on the 
pathophysiological impact of smoking, mainly demonstrating the 
functional changes induced by one single cigarette, the duration of 
the observed deleterious effects and the existence of any cumulative 
effects. Thus, this work aims at evaluating the acute effects of 
smoking (one cigarette) on vascular function in young and healthy 
short-term smokers and passive smokers, focusing on the study of 
endothelial function and arterial stiffness.
METHODS
Population and Study design 
Ninety participants of both genders (56 females), aged between 
18 and 25 years old were enrolled in a quasi-experimental study. 
Participants were recruited from the students’ community of the 
Polytechnic Institute in Coimbra, Portugal. Participants were all 
clinically healthy and free of any chronic medication. Thirty active 
smokers’ were selected to participate in the study, all of them having 
a smoking habit of less than 2 years duration. Sixty non-smokers 
matched for age, gender and overall lifestyle were also selected, 
including physical activity, alcohol and coffee consumption and 
dietary pattern. All participants were sedentary, with recreational 
alcohol consumption habits and low coffee intake. The diet pattern 
was verified with the PREDIMED questionnaire[11,12], and an overall 
low adherence to the Mediterranean diet was found (mean score: 6.9 
± 1.2). Participants were divided into three groups: Active exposure 
group (AG), including active smokers; passive exposure group (PG) 
and non-exposure control group (CG), each with 30 participants. 
    The study was conducted according to the guidelines of the 
Declaration of Helsinki and approved by the Ethics Committee of 
the Polytechnic Institute of Coimbra. Anonymity and confidentiality 
of the collected data were assured, since the study was developed for 
scientific purposes only, free of any financial or economic interests. 
All participants signed an informed consent prior to the study. 
Heart Rate and Blood Pressure
Heart rate (HR) and brachial blood pressure (bBP) were obtained 
using an automatic and clinically validated device (Riester ri-
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data, adjusting for the baseline data (entering as a covariate into the 
model). A 2-tailed p<0.05 was considered significant.
RESULTS
Population
Ninety healthy Caucasian participants were enrolled in this study. 
Ages ranged from 18 to 25 years and females were predominant 
(66.7%). The smokers consumed a mean 9.33 ± 5.18 cigarettes/
day for up to two years. Participant’s baseline characteristics are 
summarized in table 1. No significant differences were observed in 
the overall baseline clinical and demographic characteristics, with 
the exception for the baseline FMD, which was significantly lower in 
the AG (7.5 ± 2.8%) comparing with both the CG and the PG (12.3 ± 
5.4% and 12.5 ± 4.3%, respectively; p = 0.001 for AG versus CG and 
PG; p = 0.996 for CG versus PG).
Heart Rate and Blood Pressure
All the values obtained in either evaluation moments were within 
normality range. The HR had a significant increase in the AG with 
an increase of 9.6 ± 2.0 bpm from the baseline moment to the post 
smoking moment (p < 0.001), explaining a significant inter-group 
difference in the HR between the AG and both the CG and the PG 
(p = 0.001). No differences in HR were found between the CG 
and the PG in the second evaluation. Regarding brachial BP, all 
values increased significantly in the AG 30 minutes after smoking a 
cigarette, as depicted in table 2. A trend for an increase in brachial BP 
was also observed in the PG group, reaching statistical significance 
for the bDBP, bMAP and the bPP. These increases in bBP in the 
AG and the PG resulted in a significantly higher bBP profile in 
comparison with the CG (Table 2).
Pulse Wave Velocity and Pulse Wave Analysis 
The within-group analysis concerning PWV and PWA parameters, 
presented in table 3, depicted significant variations only in the AG 
participants, with the central pressures increasing from 106.8 ± 8.6 
mmHg to 115.2 ± 7.1 mmHg (SBP; p < 0.001) and from 41.3 ± 9.2 
mmHg to 45.1 ± 8.4 mmHg (PP; p = 0.029), and PWV increasing 
from 5.6 ± 0.7 m/s to 6.1 ± 0.2 m/s (p = 0.023). The differences 
maintained statistical significance after adjusting the analysis HR 
variation. No significant variations were observed within the CG and 
the PG, although an increase in the average values of cSBP, cPP and 
PWV was also identified after exposition in the PG participants.
Flow Mediated Dilatation
Regarding FMD, lower baseline values were identified in the 
AG as compared with the CG and the PG (Table 1 and figure 1). 
Considering the FMD changes after the exposition, a significant 
decrease was observed in the AG (Figure 1, right upper and lower 
panel) and no changes were observed in the CG and the PG. After 
the exposition, the FMD was significantly lower in the AG compared 
with the CG and the PG (p < 0.001), and a significant Time*Group 
interaction was observed for [F(2,41)=4.7; p = 0.01]. No significant 
differences were observed between the CG and the PG, even though 
the final average FMD was lower in the PG. Interestingly, there was 
a significant correlation between the number of cigarettes/day and 
the baseline values of FMD in the AG, with lower values of FMD for 
increasing number of cigarettes/day (r = - 0.432; p < 0.05).
DISCUSSION
The cardiovascular risk associated with smoking is a consequence 
    A basal measurement of the diameter of the right brachial 
artery in a linear plane was made, as the distance between the two 
hyperechogenic rows closest to the intima of the vessel. After 
determining the basal diameter (D1), a cuff was placed on the 
forearm, distal to the site of the ultrasound assessment, and was 
inflated into a suprasystolic pressure (about 50mmHg above the 
previously measured bSBP), keeping the ischemia for a 5 minute 
period, after which the cuff was deflated. About 1 minute after the 
complete deflation of the cuff, the diameter of the brachial artery 
was measured at the same site, to determine D2, that is, the brachial 
diameter post-reactive hyperemia. The FMD was calculated as 
the percent increase in brachial diameter after reactive hyperemia, 
FMD=[(D2 - D1) / D1] x 100, providing information on the 
endothelium-dependent vasodilation. All measurements were 
blindly performed by the same experienced operator, with high 
reproducibility scores (ICC = 0.95; unpublished data), and always in 
the in the right arm of the participants.
 
Procedure
Each participant was evaluated in an adequate quite laboratory, 
with controlled temperature and humidity, and always during the 
morning. The participants abstained from alcohol, caffeine, and 
tobacco, as well as food for 8 hours before the study. All participants 
initially filled a structured questionnaire aimed at retrieving 
information on clinical personal and family history. Height and 
weight were measured, and body mass index (BMI) was calculated 
as BMI=Weight (kg)/Height2(m2). Afterward, with the participants 
in supine position, all the baseline evaluations were performed (HR, 
bBP, FMD, PWV and PWA). The participants of the AG were then 
instructed to smoke one cigarette, of the same brand (10 mg tar, 
0.8 mg nicotine and 10 mg carbon monoxide), in a smokers’ room 
available at the Institution. For each participant of the AG, one 
participant of the PG followed to the smokers’ room, to implement 
the passive exposition condition. The participants of the CG were 
instructed to wait in a quiet room near the research laboratory. 
The second evaluation occurred 30 minutes after the first moment, 
which, in the AG and the PG, corresponded to 30 minutes after being 
exposed to one cigarette, and the same measurements were obtained 
in all participants (HR, bBP, FMD, PWA and PWV). All procedures 
were implemented by the same operators of the research team.
Statistical Analysis
Data was gathered in Excel 2016 (Microsoft Office, Redmond, WA), 
and then imported to SPSS Statistics version 24 (IBM, Armonk, NY) 
for statistical analysis. A priori required sample was calculated with 
the GPower software version 3.1.9.2 (Universität Kiel, Germany) and 
a sample of 30 participants per group was identified as adequate for 
detecting a medium effect size for a power coefficient of 0.9. 
    Categorical variables were reported as frequencies and percentages, 
and χ2 or Fisher exact tests were used when appropriate. The Shapiro-
Wilks test was used to confirm normal distribution of all continuous 
variables, expressed as mean and standard deviation. Variables with 
a non-normal distribution were log-transformed (Log10). Baseline 
inter-group comparisons were made with the one-factor ANOVA. A 
2-factor mixed-design ANOVA was used to evaluate modifications 
of variables between the baselines to the post-exposition evaluation 
in each and between groups. The Greenhouse-Geisser correction was 
used when sphericity was violated, and the Bonferroni adjustment 
was adopted for multiple comparisons designed to locate the 
significant effects of a factor. For between-groups comparison, an 
additional ANCOVA was performed over the post-intervention 
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Table 1 Clinical and demographic characterization of the participants. 
CG (n = 30) PG (n = 30) AG (n = 30) ANOVA ρ  
Male, n(%) 10 (33.3) 10 (33.3) 10 (33.3) 1
Female, n(%) 20 (66.7) 20 (66.7) 20 (66.7)
Age, years 20.7 ± 1.2 20.3 ± 1.3 20.3 ± 1.3 0.984
BMI, Kg/m₂ 23.7 ± 3.4 22.3 ± 2.3 22.3 ± 2.3 0.572
Basal HR, bpm 62.3 ± 10.5 61.2 ± 8.8 61.2 ± 8.8 0.623
Basal bSBP, mmHg 114.7 ± 12.7 113.7 ± 10.4 113.7 ± 10.4 0.426
Basal bDBP, mmHg 68.3 ± 7.2 66.1 ± 10.1 66.1 ± 10.1 0.799
Basal bMAP, mmHg 81.7 ± 8.6 82.0 ± 9.9 82.0 ± 9.9 0.567
Basal bPP, mmHg 47.3 ± 9.0 47.5 ± 7.2 47.5 ± 7.2 0.611
Basal cSBP, mmHg 105.1 ± 13.1 106.9 ± 13.1 106.9 ± 13.1 0.56
Basal cPP, mmHg 40.4 ± 9.8 40.4 ± 7.1 40.4 ± 7.1 0.711
Basal PWV, ms 5.7 ± 0.9 5.6 ± 0.8 5.6 ± 0.8 0.978
Basal AIx, % -17.6 ± 13.1 -14.2 ± 12.7 -14.2 ± 12.7 0.89
Basal FMD, n 12.5 ± 4.3 12.3 ± 5.4 12.3 ± 5.4 0.001
CG: non-exposure control group; AG: active exposure group; PG: 
passive exposure group; HR: Heart rate; bSBP: systolic blood pressure; 
bDBP: diastolic blood pressure; bMAP: mean arterial pressure; bPP: 
pulse pressure; cSBP: central systolic blood pressure; cPP: central pulse 
pressure; PWV: pulse wave velocity; AIx: augmentation index; FMD: 
flow mediated dilation.
Table 2 Heart rate and brachial blood pressure variation from baseline to 
post 30 minutes in the three experimental groups. 
CG PG AG ANOVA p Interaction
HR, 
bpm
Basal 62.3±10.5 61.2±8.8 63.5±10.4 0.623 0.985
Post 58.9±8.4 60.4±18.7 73.1±14.9 0.001
Difference -3.4±2.1 -0.8±3.3 9.6±2.0
p 0.202 0.589 <0.001
bSBP, 
mmHg
Basal 114.7±12.7 113.7±10.4 116.4±10.2 0.426 0.89
Post 112.9±9.0 122.0±11.7 125.1±9.4 <0.001
Difference -1.8±2.3 8.3±2.1 8.7±1.3
p 0.6 0.091 <0.001
bDBP, 
mmHg
Basal 68.3±7.2 66.1±10.1 67.1±9.2 0.799 0.801
Post 61.2±7.2 71.0±6.6 71.7±9.3 <0.001
Difference -7.1±2.82 4.9±1.6 4.6±1.9
p 0.114 0.03 0.032
bMBP, 
mmHg
Basal 81.7±8.6 82.0±9.9 81.6±7.2 0.567 0.876
Post 78.6±7.0 88.6±7.4 87.7±7.6 <0.001
Difference -3.1±2.4 6.6±1.6 6.1±1.7
p 0.169 0.001 0.003
bPP, 
mmHg
Basal 47.3±9.0 47.5±7.2 48.9±9.9 0.611 0.193
Post 51.6±7.4 53.0±9.0 53.0±8.0 0.73
Difference 4.3±2.4 5.5±1.8 4.1±1.7
p 0.164 0.028 0.034
CG: non-exposure control group; AG: active exposure group; PG: passive 
exposure group; HR: Heart rate; bSBP: systolic blood pressure; bDBP: 
diastolic blood pressure; bMAP: mean arterial pressure; bPP: pulse 
pressure.
Table 3 Changes in pulse wave velocity, augmentation index and 
central blood pressures from baseline to post 30 minutes in the three 
experimental groups.
CG PG AG ANOVA p




Basal 105.1 ± 13.3 106.9 ± 13.1 106.8 ± 8.6 0.56 0.446





Difference 0.3 ± 3.9 5.8 ± 2.1 8.4 ± 1.5
p 0.954 0.17 <0.001
cPP, 
mmHg
Basal 40.4 ± 9.8 40.4 ± 7.1 41.3 ± 9.2 0.711 0.122
Post 40.7 ± 10.1 42.8 ± 12.3 45.1 ± 8.4 0.107
Difference 0.3 ± 1.7 2.4 ± 3.2 3.8 ± 1.5
p 0.894 0.421 0.029
PWV, 
ms
Basal 5.7 ± 0.9 5.6 ± 0.8 5.6 ± 0.7 0.978 0.8
Post 5.8 ± 0.7 5.9 ± 0.5 6.1 ± 0.2 0.6
Difference 0.1 ± 0.2 0.3 ± 0.2 0.5 ± 0.2
p 0.47 0.29 0.023
AIx, %










Difference 1.2 ± 2.8 -2.9 ± 13.7 -0.7 ± 0.8
p 0.672 0.678 0.37
CG: non-exposure control group; AG: active exposure group; PG: passive 
exposure group; HR: Heart rate; bSBP: systolic blood pressure; bDBP: 
diastolic blood pressure; bMAP: mean arterial pressure; bPP: pulse 
pressure.
of its effects over the heart and circulation, such as increase cardiac 
output, deficient vasomotor function, cardiac remodelling, systemic 
and local inflammation, platelet activation and amongst other 
molecular important effects[1-5,19]. In the present study, smoking was 
associated with significant acute changes in several cardiovascular 
parameters, reflecting an important impact over vascular function. 
Indeed, smoking just one cigarette produced significant acute 
increases in HR, brachial and central blood pressure. This immediate 
hemodynamic response may be partially explained by the direct 
effect of nicotine, a major component of cigarettes[20], stimulating 
the sympathetic nervous system and causing the release of 
catecholamine by the adrenal medulla[20-22], and was similarly found 
in other studies[23-27]. Passive exposition to smoking did not produce 
significant hemodynamic changes, as in Giannini et al[28], although 
an increase in HR and BP was also observed, thus indicating the 
presence of a slighter immediate cardiovascular impact in the passive 
smokers. Of notice, Giannini et al documented significant depression 
of endothelial function (FMD) in passive smokers, in well controlled 
environmental conditions, measuring the amount of carbon monoxide 
in the control and polluted conditions, and identifying a strong 
correlation between the FMD reduction and the carboxyhemoglobin 
level[28].
    Even though these hemodynamic adaptations may reflect 
sympathetic activation, the evidence regarding endothelial 
function depression points clearly to other causes rather than 
a mere autonomic modulation. Endothelial dysfunction is a 
pathophysiological state in which normal homeostatic properties of 
the vessels wall are damaged or lost[20], and consistently with other 
studies involving either short-term[20-25] or long-term smokers[29,30], 
our results clearly demonstrated changes in endothelial function 
as evaluated with the FMD method. It is noteworthy that baseline 
FMD was significantly lower in AG compared to both the CG and 
the PG, hence some degree of depression of endothelial function 
was already present in the smokers, as in Yufu et al[31], in which 26 
young active smokers were compared with 31 young non-smokers, 
and FMD was shown to be significantly lower in the smoking group, 
even though no significant difference was found regarding brachial-
ankle PWV. Of notice also is the identification of an immediate and 
severe depression of endothelial function in such young and short-
term group of smokers, indicating a clear effect over the production 
of NO[22], to which the secondary secretion of vasoconstrictors, such 
as endothelin[32], together with increased oxidative stress that further 
reduces NO production[9], adds to the central direct effect of nicotine, 
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increasing the sympathetic signaling, and contributing additively 
to the changes in the hemodynamic state of the smokers through a 
reactive vasoconstriction[27]. Curiously, a recent study[33] demonstrated 
the ability of red wine to reverse this effects in a group of healthy 
smokers, thus suggesting that smoking increases oxidative stress and/
or decreases NO levels, and antioxidants in red wine may neutralize 
such effects and reverse its influence on FMD.
    The relaxation impairment observed in response to the exposition 
provides the basis to understand the significant changes also observed 
in PWV, a reference and integrated marker of arterial stiffness[34]. As 
in previous studies[3,27,35], PWV increased after the cigarette smoking, 
indicating an acute increase of arterial stiffness, possibly due to 
the smoking-induced endothelial dysfunction and the sympathetic 
activation[3], which in turn may produce increased smooth muscle 
tonus and vasoconstriction. As PWV directly relates to the overall 
cardiac workload, consequences are also expected to occur in the 
heart, and thus, should be addressed in future research. 
    Regarding the passive exposition condition, although no significant 
changes were identified, again, a trend towards a reduction in FMD 
was also observed in the PG, in line with previous findings[7,9,28], so 
further research is needed to identify the mechanisms of vascular 
compromise associated with passive exposition to smoking, namely 
identifying dose-dependency relations in terms of the overall amount 
of exposition and its cumulative effect over vascular biology and 
function.
    This study has several limitations that should be considered. The 
small number of participants is a significant aspect, even though the 
results were consistent in the most relevant outcomes considered 
in the study. Also, the study enrolled young healthy participants, 
with a good overall cardiovascular health, and a short-term history 
of smoking habits, so the detrimental effect of tobacco could be 
underestimated. Even so, the effect observed in the AG reveals a 
significant depression of endothelial in a particular favorable clinical 
context, and, to the best of our knowledge, is the first study of the 
acute effects of smoking in the vascular function of Portuguese young 
and healthy. Additionally, the measurements for the FMD estimations 
were performed manually, and even considering the experience of the 
operator and the blinding methodology, must be acknowledge as an 
important technical limitation[18].
    In conclusion, our results combined with the available evidences, 
clearly demonstrated that smoking only one cigarette produces 
detrimental acute effects on vascular endothelium and arterial 
stiffness in healthy and short term smokers. 
REFERENCES
1. World Health Organization (WHO). WHO global report on trends 
in tobacco smoking 2000-2025 - First edition. 2015. ISBN: 978-
92-4-151417-0.
2. Whincup PH, Gilg JA, Emberson JR, et al. Passive smoking and 
risk of coronary heart disease and stroke: prospective study with 
cotinine measurement. BMJ. 2004 Jul 24; 329(7459): 200-5. 
[DOI: 10.1136/bmj.38146.427188.55]; [PMID: 15229131]
3. Mahmud A, Feely J. Effect of smoking on arterial stiffness and 
pulse pressure amplification. Hypertension. 2003; 41(1): 183-
187. [DOI: 10.1161/01.hyp.0000047464.66901.60]; [PMID: 
12511550].
Figure 1 Changes in flow mediated dilation from baseline to post 30 minutes in the three experimental groups. CG: non-
exposure control group; AG: active exposure group; PG: passive exposure group; FMD: flow mediated dilation.
Pereira T et al . Smoking and vascular function
803
4. Binder S, Navratil K, Halek J. Chronic smoking and its effect on 
arterial stiffness. Biomed Pap Med Fac Univ Palacky Olomouc. 
2008; 152(2): 299-302. [DOI: 10.5507/bp.2008.047]; [PMID: 
19219224].
5. Messner B, Bernhard D. Smoking and cardiovascular disease: 
mechanisms of endothelial dysfunction and early atherogenesis. 
Arterioscler Thromb Vasc Biol. 2014 Mar; 34(3): 509-15. [DOI: 
10.1161/ATVBAHA.113.300156]; [PMID: 24554606].
6. Taha N, Abdel M, Amin A. Acute effects of cigarette smoking 
in habitual smokers, a focus on endothelial function. The 
Egyptian Heart Journal. 2013; 65(4): 275-279. [DOI: https: //doi.
org/10.1016/j.ehj.2012.09.003].
7. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette 
smoking is associated with dose-related and potentially reversible 
impairment of endothelium-dependent dilation in healthy young 
adults. Circulation. 1993; 88(5): 2149-2155. [DOI: 10.1161/01.
cir.88.5.2149]; [PMID: 8222109].
8. Kim JW, Park CG, Hong SJ, et al. Acute and chronic effects of 
cigarette smoking on arterial stiffness. Blood Press. 2005; 14: 80-
85. [DOI: 10.1080/08037050510008896]; [PMID: 16036484].
9. Holay MP, Paunikar NP, Joshi PP, et al. Effect of passive smoking 
on endothelial function in healthy adults. J Assoc Physicians 
India. 2004; 52: 114-117. [PMID: 15656044].
10. Celermajer DS, Adams MR, Clarkson P, et al. Passive Smoking 
and Impaired Endothelium-Dependent Arterial Dilatation in 
Healthy Young Adults. N Engl J Med. 1996; 334(3): 150-155. 
[DOI: 10.1056/NEJM199601183340303]; [PMID: 8531969].
11. Martinez-Gonzalez MA, Garcia-Arellano A, Toledo E, et al. A 
14-item Mediterranean diet assessment tool and obesity indexes 
among high-risk subjects: the PREDIMED trial. PloS one. 2012; 
7(8): e43134. [DOI: 10.1371/journal.pone.0043134]; [PMID: 
22905215].
12. Afonso L, Moreira T, Oliveira A. Índices de adesão ao padrão 
alimentar mediterrânico – a base metodológica para estudar a sua 
relação com a saúde. Revista Factores de Risco. 2014; 31: 48-55
13. Reference Values for Arterial Stiffness’ Collaboration. 
Determinants of pulse wave velocity in healthy people and in the 
presence of cardiovascular risk factors: ‘establishing normal and 
reference values’. Eur Heart J. 2010; 31(19): 2338-50. [DOI: 
10.1093/eurheartj/ehq165]; [PMID: 20530030].
14. Williams B, Mancia G, Spiering W, et al; ESC Scientific 
Document Group. 2018 ESC/ESH Guidelines for the management 
of arterial hypertension. Eur Heart J. 2018; 39(33): 3021-3104. 
[DOI: 10.1093/eurheartj/ehy339]; [PMID: 30165516]
15. Pereira T, Maldonado J, Andrade I, et al. Reproducibility of aortic 
pulse wave velocity as assessed with the new Complior Analyse. 
Blood Pressure Monitoring. 2014; 19(3): 170-5. [DOI: 10.1097/
MBP.0000000000000038]; [PMID: 24608728]. 
16. Pereira T, Maldonado J, Coutinho R, et al. Invasive validation of 
the Complior Analyse in the assessment of central artery pressure 
curves: a methodological study. Blood Pressure Monitoring. 2014; 
19(5): 280-7.[DOI: 10.1097/MBP.0000000000000058]; [PMID: 
24892879].
17. Corretti MC, Anderson TJ, Benjamin EJ, et al; International 
Brachial Artery Reactivity Task Force. Guidelines for the 
ultrasound assessment of endothelial-dependent flow-mediated 
vasodilation of the brachial artery: a report of the International 
Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 
39(2): 257-265. [DOI: 10.1016/s0735-1097(01)01746-6]; [PMID: 
11788217].
18. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow-
mediated dilation in humans: a methodological and physiological 
guideline. Am J Physiol Heart Circ Physiol. 2010; 300(1): H2-12. 
[DOI: 10.1152/ajpheart.00471.2010]; [PMID: 20952670].
19. Ali MK, Kitami M. Tobacco, Metabolic and Inflammatory 
Pathways, and CVD Risk. Glob Heart. 2012; 7(2): 121-128. [DOI: 
10.1016/j.gheart.2012.06.004]; [PMID: 25691308]
20. Toda N, Toda H. Nitric oxide-mediated blood flow regulation as 
affected by smoking and nicotine. Eur J Pharmacol. 2010; 649(1-
3): 1-13. [DOI: 10.1016/j.ejphar.2010.09.042]; [PMID: 20868673.
21. Lekakis J, Papamichael C, Vemmos C, et al. Effects of Acute 
Cigarette Smoking on Endothelium-Dependent Arterial Dilatation 
in Normal Subjects. Am J Cardiol. 1998; 81: 1225-1228. [DOI: 
10.1016/s0002-9149(98)00098-8]; [PMID: 9604954]
22. Balakumar P, Kaur J. Is nicotine a key player or spectator in the 
induction and progression of cardiovascular disorders? Pharmacol 
Res. 2009; 60: 361-368. [DOI: 10.1016/j.phrs.2009.06.005]; 
[PMID: 19559087].
23. Miyata S, Noda A, Ito Y, et al. Smoking acutely impaired 
endothelial function in healthy college students. Acta Cardiol. 
2015 Jun; 70(3): 282-5. [DOI: 10.1080/ac.70.3.3080632]; [PMID: 
26226701. 
24. Ozaki K1, Hori T, Ishibashi T, et al. Effects of chronic cigarette 
smoking on endothelial function in young men. J Cardiol. 2010 
Nov; 56(3): 307-13. [DOI: 10.1016/j.jjcc.2010.07.003]; [PMID: 
20943346].
25. Yufu K, Takahashi N, Okada N, et al. Influence of systolic blood 
pressure and cigarette smoking on endothelial function in young 
healthy people. Circ J. 2009 Jan; 73(1): 174-8. Epub 2008 Nov 29. 
[DOI: 10.1253/circj.cj-08-0467]; [PMID: 19043.230
26. Dalla Vecchia L, Palombo C, Ciardetti M, Porta A, Milani O, 
Kozàkovà M, Lucini D, Pagani M. Contrasting effects of acute 
and chronic cigarette smoking on skin microcirculation in young 
healthy subjects. J Hypertens. 2004 Jan; 22(1): 129-35. [DOI: 
10.1097/00004872-200401000-00022]; [PMID: 15106804].
27. Kubozono T, Miyata M, Ueyama K, et al. Acute and Chronic 
Effects of Smoking on Arterial Stiffness. Circ J. 2011; 75(3): 698-
702. [DOI: 10.1253/circj.cj-10-0552]; [PMID: 21187657].
28. Giannini D, Leone A, Di Bisceglie D, et al. The effects of acute 
passive smoke exposure on endothelium-dependent brachial artery 
dilation in healthy individuals. Angiology. 2007; 58(2): 211-217. 
[DOI: 10.1177/0003319707300361]; [PMID: 17495271].
29. Cui M, Cui R, Liu K, et al; CIRCS investigators. Associations 
of Tobacco Smoking with Impaired Endothelial Function: The 
Circulatory Risk in Communities Study (CIRCS). J Atheroscler 
Thromb. 2018 Sep 1; 25(9): 836-845. Epub 2018 Feb 8. [DOI: 
10.5551/jat.42150]; [PMID: 29415955].
30. Skaug EA, Nes B, Aspenes ST, et al. Non-Smoking Tobacco 
Affects Endothelial Function in Healthy Men in One of the Largest 
Health Studies Ever Performed; The Nord-Trøndelag Health Study 
in Norway; HUNT3. PLoS One. 2016 Aug 4; 11(8): e0160205. 
[DOI: 10.1371/journal.pone.0160205]; [PMID: 27490361].
31. Yufu K, Takahashi N, Hara M, et al. Measurement of the brachial-
ankle pulse wave velocity and flow-mediated dilatation in young, 
healthy smokers. Hypertens Res. 2007; 30(7): 607-612. [DOI: 
10.1291/hypres.30.607]; [PMID: 17785928].
32. Moustafa SM, El-elemi AH. Evaluation of probable specific 
immunotoxic effects of cigarette smoking in smokers. Egypt J 
Forensic Sci. 2013; 3: 48-52. [DOI: 10.1016/j.ejfs.2013.02.003].
33. Karatzi K, Papamichael C, Karatzis E, et al. Acute smoking 
induces endothelial dysfunction in healthy smokers. Is this 
reversible by red wine’s antioxidant constituents? Journal of the 
American College of Nutrition. 2007;  26(1): 10-5. [DOI: 10.1080
/07315724.2007.10719580]; [PMID: 17353578].
34. Laurent S, Cockcroft J, Van Bortel L, et al; European Network for 
Non-invasive Investigation of Large Arteries. Expert consensus 
document on arterial stiffness: methodological issues and clinical 
applications. European Heart Journal. 2006; 27: 2588-2605. 
[DOI: 10.1093/eurheartj/ehl254]; [PMID: 17000623].
35. Doonan RJ, Hausvater A, Scallan C, et al. The effect of smoking 
on arterial stiffness. Hypertens Res. 2010; 33(5): 398-410. [DOI: 
10.1038/hr.2010.25]; [PMID: 20379189].
